Humacyte, Inc.
HUMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$148,701 | -$110,776 | -$11,965 | -$26,477 |
| Dep. & Amort. | $7,190 | $7,719 | $8,210 | $8,241 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,137 | $0 | $6,184 | $10,146 |
| Change in WC | $311 | $6,571 | $1,029 | -$557 |
| Other Non-Cash | $36,941 | $23,181 | -$74,587 | -$72,543 |
| Operating Cash Flow | -$98,122 | -$73,305 | -$71,129 | -$81,190 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,572 | -$2,280 | -$1,048 | -$220 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$10,107 | -$8,000 |
| Inv. Sales/Matur. | $0 | $2,107 | $16,000 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,572 | -$173 | $4,845 | -$8,220 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,579 | $5,701 | -$1,981 | $27,930 |
| Stock Issued | $45,926 | $566 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $70,836 | -$1,760 | $535 | $239,053 |
| Financing Cash Flow | $114,183 | $4,507 | -$1,446 | $266,983 |
| Forex Effect | $0 | -$209 | $0 | $0 |
| Net Chg. in Cash | $14,489 | -$69,180 | -$67,730 | $177,573 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $80,801 | $149,772 | $217,502 | $39,929 |
| End Cash | $95,290 | $80,592 | $149,772 | $217,502 |
| Free Cash Flow | -$99,694 | -$75,585 | -$72,177 | -$81,410 |